Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

IBIO US Equity

iBio, Inc.Health Care · Pharmaceutical Preparations · CIK 1420720 · FY ends Jun 30
$1.49
+0.04 (+2.76%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 4 13G
DateEventWhat happened / filerSource
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Lynx1 Capital Management LPsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Vestal Point Capital, LPsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Cormorant Asset Management, LPsec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Affinity Asset Advisors, LLCsec.gov ↗
2026-08-048-K 8.01Other eventssec.gov ↗
2026-08-048-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-178-K 8.01Other eventssec.gov ↗
2026-07-178-K 5.08Shareholder director nominationssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-17

Every row is a filed document, checked against its EDGAR index.